NEW PROVIDENCE, N.J.,
Sept. 29, 2020 /PRNewswire/
-- Vertice Pharma, a specialty pharmaceuticals company focused
on improving patients' health, announced today that Don DeGolyer will join the Company's board of
directors, promoting Scott Meyers to
Chief Executive Officer ("CEO").
Mr. Meyers joined Vertice Pharma in 2016 as Chief Operating
Officer during which time he helped the Company build key
operational capabilities across manufacturing, quality, research
& development, regulatory affairs, new product selection, new
product launches, and business development. He has over 20
years of pharmaceutical experience, most recently before Vertice as
Vice President & General Manager of Fougera Inc., a Sandoz /
Novartis branded and generic dermatology business. He was formerly
a consultant for McKinsey & Company's pharmaceutical practice
and a Chemical Engineer for Merck & Co.
"Vertice Pharma's focus on delivering high-quality and
affordable pharmaceutical products has an incredible impact on
patients and reflects the mission that has driven me throughout my
career. In this next phase, I look forward to working with the
Vertice team to advance our strategy through new products and
initiatives," said Scott Meyers. "I
also want to thank Don for his mentorship throughout my career and
his leadership of our company over the past five years. I look
forward to working with him on our board of directors."
Mr. DeGolyer founded Vertice Pharma in 2015 with a unique focus
on acquiring specialty pharmaceutical companies and products,
including both branded and generic products, to create a durable
specialty pharmaceutical business of scale. By building a strong
leadership team with proven track records in the pharmaceutical
industry, Mr. DeGolyer has positioned Vertice Pharma to succeed in
a complex and rapidly evolving environment.
"I founded Vertice Pharma with the vision to improve patients'
health through acquiring and developing branded and generic
specialty pharmaceuticals and maximizing their potential. I am
incredibly proud of what the entire team has accomplished to-date
and am excited to support the company's continued growth through my
more active role on the board," said Don
DeGolyer. "Scott has been a critical partner to me since the
founding of the company, and I am excited to see him step into his
next role as CEO and to lead Vertice into its next chapter of
growth."
About Vertice Pharma
Vertice Pharma is a specialty
pharmaceutical company focused on improving patients' health.
Vertice Pharma develops, manufactures, markets, and distributes
high-quality and affordable pharmaceutical products through its
operating companies. Vertice Pharma has global headquarters in the
United Kingdom and United States headquarters in New Jersey. For more information visit
www.verticepharma.com
Media Contact
Kimberly
Branch
727-530-1633 x276
View original
content:http://www.prnewswire.com/news-releases/vertice-pharma-announces-leadership-change-301140379.html
SOURCE Vertice